| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sale+OE | 10,000 | $27.37 | $273,740.73 | -1.9% | |
| Jul 2, 2020 | Kumar Neil | CEO And President | Sell | 143,470 | $30.75 | $4,411,357.06 | -1.6% | |
| Jul 1, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sale+OE | 10,000 | $30.97 | $309,701.26 | -1.3% | |
| Jul 1, 2020 | Stephenson Brian C | See Remarks | Sell | 10,800 | $30.93 | $334,052.67 | -1.2% | |
| Jun 30, 2020 | Turtle Cameron | See Remarks | Sale+OE | 10,000 | $32.66 | $326,623.04 | -33.4% | |
| Jun 8, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sell | 606 | $30.01 | $18,185.25 | -0.1% | |
| Jun 8, 2020 | Stephenson Brian C | See Remarks | Sell | 2,000 | $30.00 | $60,001.60 | -0.7% | |
| Jun 8, 2020 | Kumar Neil | CEO And President | Sell | 10,600 | $30.01 | $318,125.08 | -0.5% | |
| Jun 3, 2020 | Henderson Michael Thomas58 | Chief Business Officer | Sell | 784 | $30.04 | $23,548.54 | -0.3% | |
| Jun 3, 2020 | Stephenson Brian C | See Remarks | Sell | 1,600 | $30.04 | $48,071.84 | -0.5% |